Otto Krieger

Linz, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification.

The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification.

Journal: Leukemia

Published: June 23, 2023

Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significance.

Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significance.

Journal: Genes, chromosomes & cancer

Published: May 13, 2018

Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes.

Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes.

Journal: Blood

Published: August 19, 2016

Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).

Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 23, 2015

Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM).

Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM).

Journal: Leukemia

Published: January 31, 2015

10th anniversary of the Austrian MDS Platform: aims and ongoing projects.

10th anniversary of the Austrian MDS Platform: aims and ongoing projects.

Journal: Wiener klinische Wochenschrift

Published: July 14, 2014

Clustering of comorbidities is related to age and sex and impacts clinical outcome in myelodysplastic syndromes.

Clustering of comorbidities is related to age and sex and impacts clinical outcome in myelodysplastic syndromes.

Journal: Journal of geriatric oncology

Published: September 19, 2013

Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis.

Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis.

Journal: Annals of hematology

Published: June 11, 2013

Monosomal karyotype in MDS: explaining the poor prognosis?

Monosomal karyotype in MDS: explaining the poor prognosis?

Journal: Leukemia

Published: April 05, 2013

Proposed score for survival of patients with myelodysplastic syndromes.

Proposed score for survival of patients with myelodysplastic syndromes.

Journal: European journal of clinical investigation

Published: February 11, 2013

Revised international prognostic scoring system for myelodysplastic syndromes.

Revised international prognostic scoring system for myelodysplastic syndromes.

Journal: Blood

Published: June 29, 2012

New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.

New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 15, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026